Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

SELL
$1.98 - $2.42 $14,349 - $17,537
-7,247 Reduced 32.85%
14,815 $35,000
Q2 2022

Aug 09, 2022

BUY
$2.21 - $2.7 $15,993 - $19,539
7,237 Added 48.82%
22,062 $50,000
Q1 2022

May 17, 2022

BUY
$2.37 - $3.24 $35,135 - $48,033
14,825 New
14,825 $36,000
Q4 2021

Feb 17, 2022

SELL
$2.92 - $3.76 $144,659 - $186,274
-49,541 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$3.28 - $4.07 $162,494 - $201,631
49,541 New
49,541 $186,000
Q2 2020

Aug 07, 2020

SELL
$1.58 - $2.86 $29,068 - $52,618
-18,398 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$2.74 - $4.2 $50,410 - $77,271
18,398 New
18,398 $61,000

Others Institutions Holding THTX

# of Institutions
1
Shares Held
29.2K
Call Options Held
0
Put Options Held
0

About Theratechnologies Inc.


  • Ticker THTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,141,600
  • Market Cap $114M
  • Description
  • Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...
More about THTX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.